|
|
Blood, 15 March 2008, Vol. 111, No. 6, pp. 3034-3041.
Prepublished online as a Blood First Edition Paper on December 26, 2007; DOI 10.1182/blood-2007-06-089987.
Previous Article | Next Article 
Submitted June 5, 2007
Accepted December 5, 2007
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
Lisbeth F.A. Maurissen, M. Christella L. G. D. Thomassen, Gerry A. F. Nicolaes, Bjorn Dahlback, Guido Tans, Jan Rosing, and Tilman M. Hackeng*
Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, Maastricht, Netherlands
Division of Clinical Chemistry, The Wallenberg Laboratory, University Hospital, Malmo, Lund University, Malmo, Sweden
* Corresponding author; email: t.hackeng{at}bioch.unimaas.nl.
Protein S expresses cofactor activity for activated protein C (APC) by enhancing the APC-catalyzed proteolysis at R306 in factor Va. It is generally accepted that only free protein S is active, and that complex formation with C4b-binding protein (C4BP) inhibits the APC-cofactor activity of protein S. However, the present study shows that protein S-C4BP expresses APC-cofactor activity, and stimulates APC-catalyzed proteolysis at R306 more than 10-fold, but instead inhibits proteolysis at R506 by APC 3- to 4-fold. Free protein S stimulates APC-catalyzed cleavage at R306 approximately 20-fold, and has no effect on cleavage at R506. The resulting net effect of protein S-C4BP complex formation on APC-catalyzed factor Va inactivation is a 6- to 8-fold reduction in factor Va inactivation when compared to free protein S, which is not explained by inhibition of APC-cofactor activity of protein S at R306, but by generation of a specific inhibitor for APC-catalyzed proteolysis at R506 of factor Va. These results are of interest for carriers of the factor VLeiden mutation (R506Q), as protein S-C4BP effectively enhances APC-catalyzed factor Va (R306) inactivation in plasma containing factor VLeiden.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. M. Hackeng and J. Rosing
Protein S as Cofactor for TFPI
Arterioscler Thromb Vasc Biol,
December 1, 2009;
29(12):
2015 - 2020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C McCann and B. N Ames
Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?
Am. J. Clinical Nutrition,
October 1, 2009;
90(4):
889 - 907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Saller, A. C. Brisset, S. N. Tchaikovski, M. Azevedo, R. Chrast, J. A. Fernandez, M. Schapira, T. M. Hackeng, J. H. Griffin, and A. Angelillo-Scherrer
Generation and phenotypic analysis of protein S-deficient mice
Blood,
September 10, 2009;
114(11):
2307 - 2314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Lijfering, R. Mulder, M. K. ten Kate, N. J. G. M. Veeger, A. B. Mulder, and J. van der Meer
Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives
Blood,
February 5, 2009;
113(6):
1225 - 1230.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|